UF
REGN icon

Univest Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Univest Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Sell
14,206
-5,194
-27% -$3.98M 0.62% 40
2025
Q4 		$15M Sell
19,400
-923
-5% -$627K 0.79% 27
2025
Q3 		$11.4M Sell
20,323
-223
-1% -$126K 0.64% 39
2025
Q2 		$10.8M Buy
20,546
+2,127
+12% +$1.19M 0.65% 40
2025
Q1 		$11.7M Buy
18,419
+4,217
+30% +$2.9M 0.76% 30
2024
Q4 		$10.1M Sell
14,202
-1,514
-10% -$1.27M 0.64% 42
2024
Q3 		$16.5M Buy
15,716
+10,024
+176% +$11.2M 1.09% 25
2024
Q2 		$5.98M Sell
5,692
-158
-3% -$153K 1.66% 17
2024
Q1 		$5.63M Sell
5,850
-1,159
-17% -$1.1M 1.58% 21
2023
Q4 		$6.16M Sell
7,009
-115
-2% -$94.7K 1.82% 16
2023
Q3 		$5.86M Buy
7,124
+448
+7% +$352K 1.96% 12
2023
Q2 		$4.8M Sell
6,676
-474
-7% -$365K 1.45% 22
2023
Q1 		$5.87M Buy
7,150
+2,107
+42% +$1.59M 1.83% 15
2022
Q4 		$3.64M Sell
5,043
-998
-17% -$736K 1.15% 33
2022
Q3 		$4.16M Buy
+6,041
New +$3.8M 1.36% 22

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Univest Financial's REGN Position: Q1 2026 in Review

Univest Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 27% in Q1 2026, selling an estimated $3.98M and leaving 14,206 shares worth $11M. The position accounts for 0.62% of the portfolio, ranked #40.

Univest Financial first reported a position in REGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $16.5M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Univest Financial held 14,206 shares of Regeneron Pharmaceuticals worth $11M as of Q1 2026.
  • Univest Financial sold 5,194 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $3.98M.
  • Regeneron Pharmaceuticals made up 0.62% of Univest Financial's portfolio in Q1 2026, its #40 holding.
  • Univest Financial first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Univest Financial's Regeneron Pharmaceuticals position peaked at $16.5M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Univest Financial's 13F filing for Q1 2026, filed 1 May 2026.